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A b s t r a c t
Background: Atrial septal defect (ASD) type 2, according to current standards, is closed percutaneously usually after the child 
has reached the age of four to five years. There are limited data regarding such treatment in younger infants. 
Aim: We sought to evaluate the feasibility, safety, and efficacy of percutaneous ASD closure in children under three years of age.
Methods: The research group consisted of 157 children less than three years old with haemodynamically significant ASD, 
who underwent effective transcatheter ASD closure in a single tertiary centre between 1999 and 2014. The mean procedural 
age of the treated children was 2.2 years and mean weight was 12.5 kg. In all cases nitinol wire mesh devices were applied 
(mostly Amplatzer Septal Occluders). ASD was closed using standard technique (except a few cases wherein the left disc of 
the implant was inserted initially into the right pulmonary vein to prevent oblique position of the device). Procedure-related 
complications were divided into major and minor ones.
Results: Atrial septal defect was closed in 149 children: 97 with a single ASD and 52 with double/multiple ASD. The procedure 
was abandoned in eight patients (three with single and five with double/multiple ASD). No death or implant embolisation 
occurred during the procedure or follow-up, and there was one case of major postprocedural complications. Normalisation 
of the right ventricular diameter occurred in all patients during one-year follow-up. In the majority of children acceleration 
of physical development and resolution of accompanying morbidity were observed in follow-up.
Conclusions: Percutaneous ASD closure can be performed safely in children under three years of age with low risk of peri- or 
postprocedural complications.
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INTRODUCTION
Atrial septal defect (ASD) comprises 5.9% to 22% of all con-
genital heart defects. In neonates and infants left-to-right shunt 
is limited by higher pulmonary vascular resistance (PVR) and 
impaired right ventricular (RV) susceptibility. With a decrease 
in PVR the shunt increases; however, most patients remain 
asymptomatic. Small ASDs can close spontaneously whereas 
large ones, as a rule, do not (they may even increase in size). 
Due to an extension of the right atrium (RA), development of 
arrhythmias is frequent (usually in adulthood), the most serious 
of which are atrial fibrillation or atrial flutter. Late effects of 
significant ASD are atrioventricular valve insufficiency (espe-
cially the tricuspid valve), sinus node dysfunction, congestion, 
and even premature cardiac death. In particular cases ASD 
leads to irreversible pulmonary vascular disease (Eisenmenger 
syndrome). Recurrent upper respiratory tract infection, un-
satisfactory weight gain or heart failure exacerbation in early 
childhood are other manifestations of ASD, and the reason 
behind them remains unclear. Percutaneous ASD closure, ac-
cording to current standards, is typically performed after the 
child has reached the age of four to five years [1–6]. In younger 
patients with heart failure symptoms the intervention should 
be undertaken in advance. The indication for ASD closure is 
a significant left-to-right shunt (pulmonary to systemic flow 
ratio > 1.5) manifested by enlargement of the RA and RV; 
however, the majority of ASD treatment recommendations 
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have arisen when the surgery (with extracorporeal circulation) 
was the only possible method of treatment. New transcatheter 
(TC) techniques of ASD closure have proven to be as effective 
as surgery, but with lower complication rate, and they are 
nowadays considered to be the treatment of choice [7, 8]. 
The aim of the study was to evaluate the feasibility, safety, and 
efficacy of percutaneous secundum ASD closure in children 
less than three years old in a single tertiary centre. To the best 
of our knowledge, it is the largest analysed group of young 
children in whom ASD was closed percutaneously [9–21].
METHODS
Patients
Overall, 157 children (110 girls) under three years of age with 
significant secundum ASD, who were referred for TC of ASD 
between September 1999 and April 2014, were enrolled 
in the study. The morphology of ASD, right heart cavities, 
as well as other miscellaneous heart defects, were assessed 
by transthoracic echocardiography (TTE). Transoesophageal 
echocardiography (TEE) was performed before the proce-
dure for confirmation of the diagnosis and TC guidance. The 
procedure was successful in 149 (94.9%) children, who were 
included in subsequent analysis. There were 97 patients with 
a single and 52 patients with double/multiple ASD. The pa-
tients were 0.5 to 3.0 years old (mean age 2.2 ± 0.6 years) 
and their mean weight was 12.6 ± 2.5 kg (range 6.5–20 kg). 
The analysed population included 145 children with normal 
karyotype and four with trisomy 21 (Down syndrome). Ac-
companying heart defects were diagnosed in 32 patients and 
included valvular stenosis of the pulmonary artery — gradi-
ent above 40 mmHg (n = 8), insignificant pulmonary valve 
stenosis — gradient below 40 mmHg (n = 8), insignificant 
patent ductus arteriosus (n = 4) and ventricular septal defect 
(n = 4), left superior vena cava (n = 1), and coarctation of the 
aorta (n = 1). RV dilation was present in all but two children, 
who underwent surgical correction of complex cyanotic heart 
defect in the neonatal period with bidirectional shunt through 
ASD. Informed consent was signed by all guardians.
Procedure
The exact size and morphology of the defect was evaluated 
by TEE. Sufficient ASD rims (at least 5 mm) were necessary to 
attempt the TC; the exception was the aortic rim, which could 
be residual or absent. However, if a residual aortic rim was ac-
companied by another floppy rim, the patient was disqualified 
from the procedure due to high risk of failure. In all children 
the ratio of the applied implant diameter (expressed in mm) 
to body weight (expressed in kg) was determined. Generally, 
when the ratio is > 1.0, occluder was considered as a big one. 
In the analysed group of patients this parameter ranged 
from 0.47 to 2.27 (mean 1.0 ± 0.3; > 1.0 — 65 patients, 
1.0 — 18 patients, < 1.0 — 66 patients).
Three types of implants were used, all made of nitinol 
wire mesh: Amplatzer Septal Occluder (St. Jude Medical, Inc., 
Minneapolis, MN, USA; now Abbott), Amplatzer Multi-Fenes-
trated Septal Occluder — “Cribriform,” and Cardi-O-Fix ASD 
Occluder (Starway Medical Technology, Inc., Beijing, China), 
which was used in relatively heavier, most often older patients 
(who needed an application of a larger delivery system). All 
procedures were performed under general anaesthesia with 
endotracheal intubation, cefazolin and heparin (100 IU/kg) 
were given to all patients. Diagnostic right heart catheterisation 
was done in all patients before the procedure. In two patients 
after complex cyanotic heart defect surgery with bidirectional 
shunt through ASD a balloon ASD occlusion test was carried 
out for 15 min, during which oxygen saturation, and venous 
and arterial pressures were monitored. In cases with increased 
oxygen saturation (pulse oximeter) without increase in venous 
pressure the test was considered to be positive. In 50 of 
149 patients (33.5%) the balloon “stop flow” calibration of 
ASD was performed (St. Jude Medical, Inc., Minneapolis, MN, 
USA; now Abbott) in order to choose the appropriate implant 
size. In patients with centrally located defect and stable atrial 
septum implants of diameter 20% to 30% greater than that 
specified in TEE were used. TC was usually performed ac-
cording to standard protocol, except in a few cases wherein 
the left atrial disc of the device was initially inserted into, 
and opened in the right upper pulmonary vein to prevent 
oblique position of the device; thereafter, the right atrial disc 
was opened in the RA. After pulling the entire system, the left 
atrial disk was ejected to the left atrium. After the procedure 
proper position of the device in all patients was confirmed 
by TEE. Before the implant was released, a so-called “Min-
nesota wiggle” manoeuvre (consisting in pushing and pulling 
the delivery system) was performed to ensure stable position 
of the implant in ASD. 
Follow-up
Subsequent control examinations after the procedure, includ-
ing electrocardiography (ECG) and TTE, were performed after 
one day, three, six, and 12 months and thereafter yearly in our 
outpatient clinic. All patients were given acetylsalicylic acid 
(ASA) for six months (3–5 mg/kg). Complications related to the 
procedure were divided into minor and major ones. Minor 
complications included embolisation of the device with suc-
cessful transcatheter removal, transient arrhythmias requiring 
treatment (pharmacotherapy or cardioversion), ECG changes 
(ST-T changes), insignificant valve dysfunction, haematoma 
or other complications at the place of venous access, venous 
thrombosis, and respiratory infections in the postoperative 
period. Major complications comprised cerebral embolism, 
endocarditis, arrhythmias requiring pacemaker implantation 
or long-term antiarrhythmic therapy, device embolisation 
requiring urgent surgery, tissue erosion surrounding the 
implant, pericardial tamponade requiring intervention, or 
death. The follow-up period ranged from 0.1 to 14.7 years 
(mean 6.0 ± 3.5 years). Fourteen (10.7%) patients were lost 
to follow-up.
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Statistical analysis
The database was created in Microsoft Excel 97 — 2003. Aver-
age values and standard deviations of individual parameters 
were calculated. Comparison of right and left ventricular 
proportions was carried out using the Fisher exact test and, 
when necessary, Student t test. Differences were considered 
statistically significant when p < 0.05.
RESULTS
Transcatheter ASD closure was abandoned in eight patients 
(three with single and five with double/multiple ASD) because 
of oblique position of the implant in a relatively large or 
unfavourable defect. ASD was sucesfully closed in 149 pa-
tients. There were no periprocedural complications. No early 
or late embolisations were observed. Complications during 
the follow-up period are discussed below. In all patients 
(except for two children after complex cyanotic heart defect 
surgery with bidirectional shunt through ASD) the indication 
for ASD closure was RV dilatation with left-to-right shunt at 
the level of the atrial septum. Other indications included slow 
weight gain (below the 25th percentile; n = 38), significant 
pulmonary valve stenosis (n = 8), increased sweating and easy 
fatigue (n = 31), frequent respiratory infections (n = 27), or 
strong parental request (n = 43). Mean ASD diameter on TEE 
was 10.3 ± 3.2 mm (single ASD group) and 11.6 ± 3.0 mm 
(double/multiple ASD group). There were eight children with 
multiperforated atrial septal aneurysm. Mean implant size 
to body weight ratio was 1.0 ± 0.3 (range 0.4–2.3). In the 
double/multiple ASD group, weight gain before the procedure 
was worse than in the single ASD group (position on a centile 
chart below the 25th percentile: multiple ASD 19/52 patients 
[36.5%] vs. single ASD 19/97 patients [19.6%], p < 0.05). In 
children with bidirectional shunt through ASD (n = 2) the bal-
loon occlusion test proved to be positive. Mean fluoroscopy 
time was 4.5 ± 3.6 min. 
Out of 60 patients in whom body weight analysis was 
possible, in six, 12, 18, 24, 30, and 36 months after the pro-
cedure, the trend lines of the centile channel were determined 
(Fig. 1). In the analysed group there was an increase in the 
percentile channel (body weight to age) in 33 (55%) patients 
and a decrease in the percentile channel in 11 (18.3%) pa-
tients. In 16 (26.7%) patients the percentile channel during the 
observation period did not change. Patients with the greatest 
drop in the percentile channel had comorbidities, such as 
bronchial asthma, frequent respiratory infections, and gas-
troenterological problems. Table 1 presents ASD morphology 
details in the single and multiple ASD groups. In both groups 
the significant RV dimension and proportions of left to right 
ventricle decreased during one-year follow-up (Figs. 2, 3).
Types of occluders 
In 145 (97.3%) patients Amplatzer Septal Occluders and in 
two (1.4%) patients with multiperforated interatrial septum 
aneurysm Amplatzer Multi-Fenestrated Septal Occluders 
— “Cribriform” (18 and 25 mm) were used. In the remaining 
two patients (1.4%; 2.6 and 3 years old; with body weight 
15 and 18 kg, respectively) Cardi-O-Fix devices (10 and 
14 mm) were used; in both, a 7-F delivery sheath was applied. 
Figure 1. The trend of channel change on a percentile grid (body weight to age) over the observation period of 36 months
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In the group of patients with a single ASD the diameter of oc-
cluders ranged from 5 to 24 mm (mean 12.3 ± 3.3 mm) and 
in the group of patients with double/multiple ASD it ranged 
from 6 to 25 mm (mean 12.4 ± 3.3 mm) — not statistically 
significant. In two patients with bidirectional shunt, 5- and 
9-mm Amplatzer Septal Occluders were delivered. 
Other interventions performed simultaneously 
with the ASD closure
In eight (5.4%) children with significant pulmonary stenosis, 
pulmonary balloon valvuloplasty prior to transcatheter ASD 
closure was performed (six patients with a single ASD) with 
gradient reduction from 56.0 to 20.4 ± 4.8 mmHg. In one 
infant with ASD and aortic recoarctation, successful balloon 
angioplasty was done with gradient reduction from 35 to 
12 mmHg. 
Complications
Major complications during the procedure or follow-up 
occurred in one patient, who developed supraventricular 
tachycardia requiring long-term antiarrhythmic therapy for 
two years after the procedure (n = 1). Minor periprocedural 
complications included respiratory tract infection (n = 5), 
anaemia requiring transfusion of the erythrocyte mass (n = 1), 
and a small amount (2–3 mm) of fluid in the pericardium 
(n = 1). Mild arrhythmias and conduction disturbances were 
found during the procedure in five patients: supraventricular 
tachycardia (n = 2; one patient needed adenosine bolus, in 
the other patient it resolved spontaneously), transient single 
ventricular and supraventricular extrasystoles (n = 2) and 
second-degree atrioventricular blocks (Mobitz types I and II), 
which resolved after steroid administration. In long-term ob-
servation, minor complications (mild mitral valve insufficiency) 
occurred in two patients.
DISCUSSION
According to the presented results, TC of ASD is effective 
and feasible in children under three years of age. Amplatzer 
occluders were used in the vast majority of analysed cases. Lit-
erature reports on transcatheter ASD closure in young children 
are mostly limited to short case series [8–21]. Moreover, the 
risk-benefit ratio of this procedure in young patients has not 
been clearly defined. 
This study analysed a population of 157 children under 
three years of age referred for transcatheter ASD closure, 
which is one of the largest groups in the world treated in this 
way in a single tertiary centre.
Table 1. Single and double/multiple atrial septal defect (ASD) 







Number of patients 
with double/multiple 
ASD
Aortic rim below 
5 mm/residual
30/97 (31) 13/52 (25.1)
Posterior rim 
below 5 mm
15/97 (15.5) 8/52 (15.4)
Centrally located 
defect




Data are shown as number (percentage) Figure 2. Changes in the proportion of heart cavities after the 
closure of a single atrial septal defect type II depending on the 
length of the follow-up period; LV — left ventricle; RV — right 
ventricle 
Figure 3. Changes in the proportion of heart cavities after the 
closure of a double/multiple atrial septal defect type II depen-
ding on the length of the follow-up period; LV — left ventricle; 
RV — right ventricle
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In our clinical practice ASDs are closed percutaneously 
in children and adults in equal proportions [5]. TC of ASD is 
a well-established and safe method of treatment used in chil-
dren and adults for many years in cardiac centres around the 
world. It is the method of choice in the treatment of secundum 
ASD with appropriate morphology [6]. There is compelling 
evidence that percutaneous closure is more beneficial in 
comparison to surgical treatment in terms of complications, 
frequency, and length of hospital stay [7, 8]. 
Despite the consensus that closure of significant ASD is 
necessary from the clinical point of view, discrepancies exist 
regarding the best timing due to a theoretical possibility of 
spontaneous closure as the child grows. Over the past few dec-
ades, many analyses of spontaneous ASD closure have been 
made [22, 23]. Small defects usually have a greater tendency 
to close, while larger ones tend to enlarge. However, there are 
single cases of spontaneous closure of a large ASD in young 
children [24, 25]. The fact that small defects are characterised 
by spontaneous closure or reduction in dimensions was taken 
into account in the qualification of patients for our study. In 
the literature, however, evidence exists that initially small, 
haemodynamically non-significant ASD has the potential to 
increase with the child’s growth even beyond the capabilities 
of the transcatheter method [26].
Considering available publications, it can be proposed 
that there is no clear benefit from closing ASD < 8 mm in 
asymptomatic children under three years of age. These conclu-
sions were taken into account when referring children for ASD 
transcatheter closure in our study. ASD closure is performed 
according to the applicable guidelines [1–6], usually after the 
child has reached the age of four years. However, the timing of 
the intervention should be brought forward in younger patients 
with clinical symptoms of heart failure. Based on our analysis, 
acceleration of physical development, normalisation of cardiac 
indicators, and resolution of accompanying morbidity can be 
asserted in the majority of children under three years of age 
undergoing ASD closure. Our preliminary experience indicates 
that the method can also be effective and highly beneficial in 
patients with a complex cyanotic heart defect with bidirectional 
shunt through small ASD, as in other reports [27]. 
The majority of complications were mild and usually of 
self-limiting nature. Embolisations of implants — nowadays 
rare — are presumably related to the operators’ learning curve. 
Available analyses show that residual shunt after percutaneous 
ASD closure is present in approximately 10% of cases and 
usually resolves spontaneously in the early postprocedural 
period. This was confirmed also by our results. The formation 
of thrombi on the occluder (not observed in the analysed 
group) despite the standard antiaggregation treatment (ASA 
3–5 mg/kg for half a year) is described in about 2% to 3% of 
cases, mainly in short-term follow-up. Perforation of the atrial 
wall (also referred to as erosion) and late implant embolisa-
tion occur sporadically (0.1%–0.3%), according to the United 
States Food and Drug Administration. As shown in the registry 
of Amin et al. [28], patients with residual aortic rim or lack 
thereof are particularly predisposed to such complications. In 
the presented material no cases of embolisation, erosion, or 
thrombus formation on the occluder were found in follow-up.
Transcatheter closing of ASD in children under three 
years of age helps to avoid an increase in the size of large 
ASD and the use of larger implants in older patients.
Inconveniences related to the procedure include (i) small 
size of vessels; (ii) the problem with ASD calibration with 
the balloon catheter (intended by manufacturers for use in 
adults); (iii) small atrial septum and more difficult manipula-
tions of catheters in the heart; (iv) lack of cooperation with 
the patient (general anaesthesia and longer sedation time 
required); (v) often an oblique position of the implant in the 
ASD after opening of the left atrial disc.
In conclusion, percutaneous closure of ASD is a safe 
and effective procedure in children under three years of 
age. Subjective improvement in children’s clinical state 
(better exercise tolerance) is observed after the procedure. 
Moreover, more than half of the analysed patients showed 
improved anthropometric parameters (weight gain) and ex-
perienced fewer episodes of respiratory tract infections. The 
proportions of the heart chambers normalised in all patients 
in follow-up. In two patients with complex cyanotic con-
genital heart defect with a bidirectional shunt through the 
ASD, normalisation of blood oxygen saturation as well as 
improvement in development occurred after the procedure. 
Technical difficulties encountered during percutaneous ASD 
closure can be solved with special implantation techniques 
in the majority of cases.
Conflict of interest: none declared
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WHAT IS NEW?
To the best of our knowledge, it is the largest analysed group of young children in whom atrial septal defect (ASD) was 
closed percutaneously. Our data confirm the usefulness and efficacy of transcatheter closure of ASD in this group of patients.
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